GO:0003676 | nucleic acid binding | 11.39% (9/79) | 2.09 | 0.000258 | 0.033078 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0007093 | mitotic cell cycle checkpoint | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0030173 | integral component of Golgi membrane | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0031228 | intrinsic component of Golgi membrane | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:1905819 | negative regulation of chromosome separation | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:1901988 | negative regulation of cell cycle phase transition | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0071173 | spindle assembly checkpoint | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0051985 | negative regulation of chromosome segregation | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0051784 | negative regulation of nuclear division | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0031577 | spindle checkpoint | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0007030 | Golgi organization | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0071174 | mitotic spindle checkpoint | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.27% (1/79) | 8.29 | 0.003198 | 0.034113 |
GO:0031300 | intrinsic component of organelle membrane | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0010948 | negative regulation of cell cycle process | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0006354 | DNA-templated transcription, elongation | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0006383 | transcription by RNA polymerase III | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0016593 | Cdc73/Paf1 complex | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0005666 | RNA polymerase III complex | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:2001251 | negative regulation of chromosome organization | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0009678 | hydrogen-translocating pyrophosphatase activity | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0031301 | integral component of organelle membrane | 1.27% (1/79) | 7.29 | 0.006386 | 0.044185 |
GO:0044446 | intracellular organelle part | 5.06% (4/79) | 2.41 | 0.006873 | 0.046304 |
GO:0044424 | intracellular part | 7.59% (6/79) | 1.81 | 0.007291 | 0.046661 |
GO:0003674 | molecular_function | 39.24% (31/79) | 0.89 | 0.000183 | 0.046745 |
GO:0044422 | organelle part | 5.06% (4/79) | 2.39 | 0.007286 | 0.047829 |